SEC Company Response from Sanara MedTech Inc. (SMTI) (CIK 0000714256) (SMTI) — Sep 13, 2005
Sanara MedTech Inc. (SMTI) (CIK 0000714256)
Date: Sept. 13, 2005 · CIK: 0000714256 · Accession: 0001010549-05-000645
AI Filing Summary & Sentiment
Referenced dates: July 5, 2005
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
MB 2225 East Randol Mill Road Suite 305
Arlington, Texas 76011
SOFTWARE CORPORATION (817) 633-9400 FAX (817) 633-9409
--------------------------------------------------------------------------------
September 9, 2005
United States
Securities and Exchange Commission
Washington, DC 20549
Mail Stop 6010
Re: SEC comment letter dated July 5, 2005
Dear Mr. Kuhar:
In reference to your letter of July 5, 2005 we respectively submit the
following.
Form 10-KSB for the Fiscal Year Ended December 31, 2004.
--------------------------------------------------------
Item 8A. Controls and Procedures, Page 9.
-----------------------------------------
1. We note your disclosure that your principal executive officer and principal
financial officer have evaluated your disclosure controls and procedures as of a
date within 90 days before the filing date of your annual report. Please revise
future filings to disclose management's conclusion regarding the effectiveness
of your disclosure controls and procedures as of the end of the period covered
by the annual report. Refer to Item 307 of Regulation S-B and Part III.F of
Management's Reports on Internal Control Over Financial Reporting and
Certification of Disclosure in Exchange Act Periodic Reports, Release No.
33-8238.
Response: We have corrected on our June 30, 2005 Form 10-QSB. Please review to
make sure we have complied.
2. In future filings please revise the language used in your disclosure
concerning changes in your internal control over financial reporting to indicate
whether there was any changes to your internal control over financial reporting
that has materially affected, or that is reasonably likely to materially affect,
your internal control over financial reporting, consistent with the language
used in amended Item 308(c) of Regulation S-B.
Response: We have corrected on our June 30, 2005 Form 10-QSB. Please review to
make sure we have complied.
Report of Independent Register Public Accounting Firms, Page F-2
----------------------------------------------------------------
3. We note that your corporate headquarters is located in Arlington, TX, your
operations are based in Ft. Lauderdale, FL and your accountants are located in
Phoenix, AZ. Please tell us why your auditor is from Arizona given the locations
of your headquarters and operations. While we note your auditors are registered
1
<PAGE>
with PCAOB, tell us if they are licensed to practice in Florida and Texas. If
not, tell us why you believe they were qualified to perform the audit.
Response: Clancy and Co., P.L.L.C., our independent auditors are licensed in
Texas, where our corporate headquarters are located and all of our accounting
operations are performed. The Company's operations in Ft. Lauderdale, FL,
essentially consist of office space leased for our sales force for our product.
The Company's product inventory is located in a warehouse distribution facility
in Rochester, New York.
Financial Statements
--------------------
Note 3- Business Acquisition, Page F-11
---------------------------------------
4. We see that on August 20, 2004 you acquired all of the outstanding equity
interests in Wound Care Innovations, LLC ("WCI") in consideration for the
issuance of 6,000,000 shares of restricted stock. It appears that MB Software
and WCI are under the "common control" of Mr. Cossutta and Mr. Haire as defined
by paragraph 3 of EITF 02-05. If our presumption is correct, tell us why the
transaction was not accounted for as the reorganization of entities under common
control, i.e., in a manner similar to a polling of interest with assets
transferred at their historical costs as required by paragraphs D11 to D17 of
SFAS 141. Please tell us your consideration of this accounting basis for this
transaction and specifically address your consideration of the common control of
MB Software and WCI. If you have appropriately concluded the entities are not
under common control, please explain to us what consideration you have given to
paragraphs 15 to 19 of SFAS 141 in identifying the acquiring entity. Tell us
whether you believe the transaction should be accounted for as a reverse
acquisition or recapitalization. Please support your assertions with references
to the authoritative accounting guidance upon which you relied. We may have
additional comments after reviewing your response.
Response: Mr. Cossutta and Mr. Haire are the controlling shareholders of MB and
WCI, however the product and the actual patent holder were controlled and owned
by an unrelated party with which WCI had entered into a Distribution Agreement.
Accordingly, the acquisition of WCI was effected by MB for the purpose of
obtaining the exclusive rights to the product and patent. We did not account for
the transaction as a reorganization of entities under common control for this
reason, but instead considered the transaction an acquisition, accounted for
under the purchase method of accounting because MB acquired the net assets of
WCI and obtained control over its net assets. (FAS 141, paragraph 9). MB is
considered the acquiring entity in this case as it issued its common shares as
consideration in exchange for 100% acquisition interest in WCI. MB ultimately
controls the operating and financing decisions of the resulting combined
entities as MB's president and board of directors hold a majority of MB's
outstanding common stock.
The cost of the acquired entity (WCI) was determined by the fair market value of
the 6M securities issued as consideration, as determined by published quoted
market prices. Since no cash was exchanged in the transaction, the measurement
was based on the fair value of the securities issued, since it was more clearly
evident and, thus, more reliably measurable. (FAS 141, paragraph 6)
Note 4 - Related Party Transactions, page F-12
----------------------------------------------
5. We see that you have engaged in various transactions with related parties,
including the acquisition of WCI and borrowings from related entities. Related
party transactions should be identified and the amounts separately stated on the
2
<PAGE>
<TABLE>
<CAPTION>
face of the income statement or balance sheet, if material. Additionally,
paragraphs 2 to 4 of SFAS 57 require the disclosure of the nature of the
relationships, a description of transactions, the dollar amount of transactions,
the amounts due to or from related parties and also the nature of control
relationships between related parties even if there are no transactions between
the enterprises. In accordance with SFAS 57, please tell us more about your
related party transactions and update future filings to disclose this
information.
Response: We have added the additional disclosure on our June 30, 2005 Form
10QSB. Due to related parties at December 31, 2004, represents the following:
Related party Nature of relationship Description of transaction Amounts due from
(to)
related parties
------------------------------------- ------------------------------------- --------------------------- --------------------
<S> <C> <C> <C>
HEB, LLC, a Nevada Limited Scott Haire, Chairman President, Series of funds advanced $ 70,905
Liability Company CEO and CFO of this company, for working capital
controls both entities financing purposes
and operating decisions
Araldo Cossutta, an individual Director and stockholder of the Funds advanced for (76,271)
Company working capital purposes
eAppliance Payment Solutions, Controlling owners in eAppliance Series of funds advanced (2,568)
LLC a Nevada Limited Liability Payment Solutions, LLC are the for working capital
Company President and one director of MB purposes
Software Corporation
Virtual Payment Solutions, LLC Scott A. Haire is the Series of funds advanced 22,630
a Nevada Limited Liability Manager/Member of this company, for working capital
Company controls both entities financing and purposes
operating decisions
Virtual Technology Licensing, Scott A. Haire is the Series of funds advanced 8,497
LLC a Nevada Limited Liability Manager/Member of this company, for working capital
Company controls both entities financing and purposes
operating decisions
Nevada Multicare, LLC a Scott A. Haire is the Series of funds advanced (13,655)
Nevada Limited Liability Manager/Member of this company, for working capital
Company controls both entities financing and purposes
operating decisions
--------------------
$ 9,538
====================
</TABLE>
Form 10QSB for Quarter Ended March 31, 2005
-------------------------------------------
6. We see that you pay $75,000 per year as an option fee to maintain your rights
to purchase certain property and you capitalize the amount as an other asset.
Please tell us why you believe generally accepted accounting principles permit
you to capitalize these payments rather than expense them. Please support your
assertions with references to the authoritative accounting guidance upon which
you relied. We may have additional comments after reviewing your response.
Response: We capitalized the option fee because it provides a future economic
benefit, i.e. the right to purchase the patent and related intellectual property
as described in the option agreement for one year and expiring on August 31,
2005, at which time another $75,000 option fee is due and payable or we lose our
exclusivity rights. From an accounting perspective, each year the prior year
option fee will be expensed and the current period option fee will be
capitalized. Similarly, when an event occurs that destroys the future benefit or
removes our ability to obtain it, the asset will be expensed. As disclosed in
our 2005 second quarter Form 10-QSB, the company lost its exclusive option to
3
<PAGE>
distribute the product due to a default under the agreement, and accordingly,
the option fee was expensed at that time (April 2005).
Our accounting was based on FASB Concepts Statement No. 6 "Elements of Financial
Statements a replacement of FASB Concepts Statement No. 3 (incorporating an
amendment of FASB Concepts Statement No. 2.", as defined by:
(i) paragraph 26 - "An asset has three essential characteristics: (a) it
embodies a probable future benefit that involves a capacity, singly or in
combination with other assets, to contribute directly or indirectly to future
net cash inflows, (b) a particular entity can obtain the benefit and control
others' access to it, and (c) the transaction or other event giving rise to the
entity's right to or control of the benefit has already occurred."
(ii) paragraph 33 - "Once acquired, an asset continues as an asset of the entity
until the entity collects it, transfers it to another entity, or uses it up, or
some other event or circumstance destroys the future benefit or removes the
entity's ability to obtain it."
As requested, we acknowledge the following:
o the company is responsible for the adequacy of the disclosure in the
filing;
o the staff comments or charges to disclosure in response to staff
comments do not foreclose the Commission from taking any action with
respect to the filing; and
o the company may not assert staff comments as a defense in any
proceeding initiated by the Commission or any person under the federal
securities laws of the United States.
Please let us know if you have further comments or need additional clarification
on any of the responses provided.
Sincerely,
/s/ Scott A. Haire
Scott A. Haire, President
SAH/ljs
</TEXT>
</DOCUMENT>